# R-FULL-019 — Full-paper review (P3 Adversarial Novelty SAC STRICT, target = Best Paper 8.5)

## Batch metadata

| Field | Value |
|-------|--------|
| **review_run_id** | `reviewer_20260421_092345_19_ca7877` |
| **reviewer_profile** | **P3: Adversarial Novelty SAC** (focused on Novelty D3 + Significance D2; **treats any framing similarity to existing routing/orchestration/agent/multi-agent work as a presumed reduction**; demands concrete differentiation from ≥ 3 named prior systems + falsifiable claim prior work cannot make) |
| **target_pdf** | `d:\Codes\idea04\article\build\edo_paper.pdf` |
| **pdf_sha256** | `D6A67296A7542C6D8C39CC4709CD16CCC04683FD6C0BE603D3C0B83D979C43EE` |
| **pdf_sha16** | `D6A67296A7542C6D` (same as R-FULL-017/018; verified main body 8 pages COMPLIANT; mtime 2026-04-21 08:57:21) |
| **target_score** | **8.5** (Best-Paper bar per `docs/demand.md §11.5`) |
| **prior_batch_independence** | **stateless** — no prior `review.md` from batches 01-18, no `SCIENTIST_TODO §C`. P3 last used in R-FULL-013 on older PDF `87662BD6` (DR-1 REJECT then; post-S-167 resolved). First P3 audit of SHA `D6A67296` post-S-173 stack. |
| **rulebook** | `docs/demand.md §1-§11` + `prompts/reviewer_prompt.md §2-§10` |
| **process_compliance (§1.5.0)** | **Satisfied**: `docs/demand.md` + `pdftotext -layout` of PDF (923 lines / 103635 B / 15 pages) read end-to-end. |
| **user_trigger** | User verbal explicit "现在可以再去按照一个新的审稿人角度去审 ... 按照best paper的要求严格审稿" → implicit `U-Review-19-decide`. P3 Adversarial Novelty selected because: (i) R-FULL-013 was last P3 batch but it was forced-reject by DR-1 regression on old PDF (resolved); this is **first P3 verdict on a post-S-173 clean PDF with valid DR-1**; (ii) P3's **novelty + overlap-risk** focus complements P2 (experiments) / P5 (oral) / P4 (reproducibility) / P1 (soundness) already used on same PDF — completes the 5-persona rotation; (iii) user emphasis on "Best Paper" strictness maps to P3's "framing-similarity-as-presumed-reduction" default. |

---

## Document classification

`document_type` = **full_paper**. `submission_track` = EMNLP Long Paper — Oral / Best-Paper.

**DR-1 PASS** (verified by 3 methods earlier this session). Post-S-173 theorem proofs live in new Appendix F; §3 main body retains concise theorem statements + cross-refs.

---

## Summary (≤ 100 words)

P3 Adversarial Novelty audit on post-S-173 clean PDF. **Novelty claim (organizational emergence + recursive delegation) is framing-level** — the mechanistic delta from Multi-Agent Debate (Liang 2024; Du 2024) is a degenerate-case reduction (MAD-with-terminal-only-aggregation), not a new primitive. Paper discusses MAD in 2 sentences (§2.2) but provides **zero empirical head-to-head**. Stage-2 R1/R2/R3 mechanisms are theoretical-only; delivered TCPB reduces to fixed-topology role-prior routing (Prototype Scope Box self-admits near-MetaGPT). Under P3 hard rules: **D3 = 4.0 cap (MAD overlap unaddressed)** + framing-mostly novelty + no falsifiable claim prior work cannot make → **overall 4.5 weak_reject**, oral_quality 3.0.

---

## Desk-reject risks (`desk_reject_risks`)

| ID | Status | Evidence |
|----|--------|----------|
| DR-1 | **PASS** (verified 3 methods earlier this session: fixed `build_paper.ps1` "main body p8 COMPLIANT" + pdftotext -f 8 / -f 9) |
| DR-2 | PASS | `Limitations` exact title after Conclusion |
| DR-3 | PASS | 7 items scope only; engineering in Appendix B; theorems in Appendix F |
| DR-4 | POSSIBLE – not verified | pdftotext cannot audit `acl.sty` |
| DR-5 | PASS | No process leak |
| DR-6 | PASS | B1-B5 complete |
| DR-7 | PASS | Coherent long-form |
| DR-8 | PASS | AI disclosed + Ethical section |

Net: 0 confirmed DR; 1 POSSIBLE (DR-4).

---

## Best-Paper structural compliance (`best_paper_structural_compliance`)

§11.5 12-item: **7 hard + 3 partial + 2 pass** (unchanged from R-FULL-017/018 since PDF same).

**§11.5 enforcement**: 7+ missed → `oral_quality_score ≤ 3`; P3 assigns **3.0** (same as P5 R-FULL-017; P3 less D6-strict than P5 on Figure-1 placeholder).

---

## Experiments-solidity audit (`experiments_solidity_audit`)

| Check | Status | P3 evidence (focus-on-novelty-but-rules-still-enforced) |
|-------|--------|---------------------------------------------------------|
| EXP-1 | fail | HotpotQA only |
| EXP-2 | fail | seed=42 only |
| EXP-3 | fail | no paired test |
| EXP-4 | fail | no CI |
| EXP-5 | partial | coverage 0.5 on wrong backbone |
| EXP-6 | **fail (P3 specialty-adjacent)** | **Zero external 2024-2025 SOTA baselines → P3 cannot assess novelty delta from the very systems it's most similar to (MAD, AutoGen, ChatEval)** |
| EXP-7 | partial | ±2× weight sweep |
| EXP-8 | fail | no taxonomy |

**`experiments_solidity_score` = 1 / 8**. D4 cap = 4.

**P3 NEW observation**: EXP-6 fail compounds with D3 cap — without head-to-head experimental data against MAD / AutoGen / ChatEval, the novelty claim cannot be empirically distinguished from framing-only restatement.

---

## Novelty delta audit (`novelty_delta_audit`) — P3 SPECIALTY deep audit

| # | prior_work_name | year | claimed_difference | is_concrete | is_overlap_risk | P3 notes |
|---|-----------------|------|-------------------|-------------|-----------------|----------|
| 1 | **Multi-Agent Debate (Liang et al., EMNLP 2024; Du et al., ICML 2024)** | 2024 | "MAD aggregates per-hop critiques; TCPB collapses critique to terminal-outcome only" (§2.2 2 sentences) | **true (mechanistic)** | **TRUE - UNADDRESSED** | **TCPB is MAD with `aggregator_window = full_trajectory`, `aggregation_rule = terminal_F1_sign_step`**. Under this reading, TCPB is a parameter instantiation of MAD, not a new mechanism. **Paper has zero head-to-head benchmark**; §2.2 prose-only claim. **P3 rubric §2.5.2: is_overlap_risk=true unaddressed → cap D3 at 4.** |
| 2 | AutoGen (Wu et al., ICLR 2024) | 2024 | "removes globally visible expert table, central decision node, fixed task script" (§2.1) | true | false | P3 concedes: (i) AutoGen's `GroupChatManager.select_speaker` IS a central router, so "removing central router" is a genuine mechanism-level delta. (ii) BUT: AutoGen can be configured with `speaker_selection_method='round_robin'` + null GroupChatManager, which approximates EDO's local-visibility constraint. Paper doesn't explicitly argue why AutoGen's configuration flexibility doesn't subsume EDO. **Borderline overlap; not clearly true/false.** |
| 3 | MetaGPT (Hong et al., ICLR 2024) | 2024 | "removes pre-assigned role order" | true | **borderline-TRUE** | **Prototype Scope Box item (ii) self-admits**: "four role-prior nodes (decomposer, evidence_seeker, verifier, synthesizer)" = MetaGPT's fixed-role pipeline in reduced form. Paper § 3.1 delivers decentralized-**within**-fixed-role-prior-topology = ~MetaGPT minus the orchestrator. **P3 reads: delivered Stage-1 TCPB ≈ MetaGPT simplified**; framework EDO claims are "future Stage-2"; framework-level novelty ≤ framing. |
| 4 | ChatEval (Chan et al., ICLR 2024) | 2024 | "per-hop peer critique → meta-reviewer" | true | false | Legitimate mechanism-level difference (per-hop vs terminal); but same caveat as MAD — no head-to-head. |
| 5 | Reflexion / ToT / Self-Refine (2023) | 2023 | "Single-agent self-reflection vs multi-agent terminal-outcome" | true | false | Legitimate delta; not overlap risk at framework level. |

**Additional P3 finding not in §2 Related Work (missing coverage)**:
- **MA-RAG (arXiv:2505.20096, 2025)**, **ReAgent (arXiv:2503.06951, EMNLP 2025)** — latest multi-hop QA SOTA systems cited only as Stage-2 roadmap items (via U-022 sprint dispatch). In a Best-Paper 2026/2027 submission, these 2025 systems should be **benchmarked in main tables** and differentiated mechanically.

**P3 verdict on D3**:
```
Hard rules applied:
- ≥3 named priors with concrete deltas: yes (AutoGen, ChatEval, MAD, MetaGPT, Reflexion) → passes ≥3 gate
- ≥50% concrete deltas: yes → passes concreteness gate
- is_overlap_risk=true unaddressed (MAD): YES → **cap D3 at 4** (hard rule)
- Framing-mostly novelty: yes (delivered TCPB is reduction; Stage-2 mechanisms theoretical) → floor at band 5
- Combination of known ideas (MAD + AutoGen-local-visibility + MetaGPT-role-priors) with non-trivial integration insight: NOT ARGUED in paper → band 6 ceiling if argued
```

**D3 = 4.0** (capped by MAD overlap hard rule).

---

## Dimension scores (P3 Adversarial Novelty lens)

| Dim | Score | P3 defense |
|-----|-------|------------|
| **D1 Soundness** | **6.5** | Post-S-163/S-173: 14 operational objects formalised + Appendix F 4 theorem proofs. P3 not D1-specialty; assigned 6.5 same as P5/P2. |
| **D2 Significance** | **4.0** | **P3 specialty — strict**. Delivered system = single-benchmark Pareto-negative under a framing ("organizational emergence") that no one has validated as different from multi-agent orchestration. Band 4 "Limited significance; addresses a problem few in the community care about if the mechanistic delta turns out to be MAD-degenerate"; not 5 because the pivoted claim "EDO explains when delegation overhead pays off" is not validated and could be restated in AutoGen/MAD terminology. |
| **D3 Novelty** | **4.0** (hard cap) | **P3 SPECIALTY**. MAD `is_overlap_risk=true` UNADDRESSED empirically → hard cap at 4. Plus: framework-level novelty = framing ("organizational emergence"); delivered Stage-1 TCPB ≈ MetaGPT-minus-orchestrator; Stage-2 R1/R2/R3 mechanisms are theoretical-only. Under P3: novelty budget mostly spent on re-labeling existing mechanisms. |
| **D4 Empirical** | **4.0** (cap = 4.5) | Single benchmark / single seed / no paired / no CI / no external SOTA / wrong-backbone ablations. D4 cap = 4+0.5 = 4.5 binding. |
| **D5 Reproducibility** | **6.5** | Algorithm 1 + Symbol Glossary + Appendix F + B1-B5. Band 7. |
| **D6 Clarity** | **5.5** | Figure 1 placeholder; post-S-173 compression acceptable. |
| **D7 Responsible research** | **8.0** | Limitations + Ethical band-8 coverage. |

### Secondary (S1–S8)

| S | Score | Note |
|---|-------|------|
| S1 executability | 6.5 | Stage-1 implementable post-S-163 |
| S2 falsifiability | 5.0 | Central claim ("organizational emergence") not tied to a falsifiable metric that prior systems fail |
| S3 empirical plan (design) | 5.0 | §4.4 E1-E5 reasonable but novelty of the design unclear |
| S4 technical clarity | 6.5 | Post-S-173 |
| S5 statistical rigor | 3.0 | Single seed |
| S6 baseline quality | 2.0 | Zero external |
| S7 ablation completeness | 4.0 | Null effects on wrong backbone |
| S8 writing and figures | 5.0 | Figure 1 placeholder |

**`oral_quality_score` = 3.0** — P3: §11.5 cap 3; no top-3-5% novelty signal; paper is framing + restricted-prototype-on-single-benchmark.

---

## Score calculation (deterministic)

```
raw_weighted = 0.25*D1 + 0.18*D2 + 0.15*D3 + 0.18*D4 + 0.10*D5 + 0.07*D6 + 0.07*D7
             = 0.25*6.5 + 0.18*4.0 + 0.15*4.0 + 0.18*4.0 + 0.10*6.5 + 0.07*5.5 + 0.07*8.0
             = 1.625 + 0.720 + 0.600 + 0.720 + 0.650 + 0.385 + 0.560
             = 5.260

Caps applied:
- DR-4 POSSIBLE only               → no DR cap
- D1 = 6.5 ≥ 5                     → no D1 cap
- D4 = 4.0 < 5                     → cap overall at min(5.260, D4+0.5) = 4.5 (binding)
- D3 = 4.0 < 5                     → cap overall at D3+0.5 = 4.5 (tied)
- D3 = 4.0 < 6                     → cap overall at 6.5 (not binding)
- oral_quality = 3.0 < 5           → cap at 5.5 (not binding)
- exp_solidity = 1 ≤ 3             → cap at 4.5 (tied)
- **novelty_delta_audit MAD overlap UNADDRESSED → cap overall at 5.0** (not binding; reported at D3=4)
- S6 = 2.0 < 5                     → cap at 6.0 (not binding)
- S7 = 4.0 < 5                     → cap at 6.0 (not binding)
- §11.5 7+ missed                  → cap oral at 3 (assigned 3.0)

overall = 4.5
```

| Field | Value |
|-------|--------|
| **weighted_sum_pre_cap** | **5.260** (vs R-FULL-018 P2 5.315 = -0.055 P3 stricter on D2 + S2; vs R-FULL-017 P5 5.350 = -0.090; P3 systematic stricter offset on novelty + significance bars) |
| **overall** | **4.5 weak_reject — 连续 6 轮 > 4.0** (R-FULL-014/015/016/017/018/019 covering all 5 personas P1-P5) |
| **verdict** | **weak_reject** |
| **oral_eligible** | **false** |
| **is_8_plus_ready** | **false** |
| **is_best_paper_ready** | **false** |
| **confidence** | **4 / 5** |
| **estimated_score_after_fixes** (E-017 + external SOTA + MuSiQue + Figure 1 + **MAD head-to-head** + case-study) | **5.8–6.2** borderline (P3 more cautious than P2/P5 — MAD overlap means D3 cap could still bind even after experiments close) |
| **estimated_score_after_Best-Paper-track_fixes** | **6.5–7.2** Oral border (P3 emphasizes: Best-Paper novelty needs R1/R2/R3 implementation with mechanistic-delta-not-reducible-to-MAD/AutoGen/ChatEval; paper may not reach 8.5 without this) |

---

## Top strengths (`top_strengths`)

1. **S-163 Symbol Glossary + S-173 Appendix F** — Stage-1 TCPB implementable from paper-alone; formal theorems preserved in Appendix F (1-locality / complexity / convergence / reduction); 4 operational-object-debt that P1 flagged in R-FULL-011 is closed.
2. **Honest framing of delivered-system limitations** — §Limitations (6) Pareto-domination + §5 Conclusion "narrower supported claim"; Best-Paper reviewers value this.
3. **Dual-section honesty** (Limitations + Ethical Considerations) band 8 D7.
4. **§4.5 cost-normalised Pareto-axis reframing** (`F1/1k tok +84%` vs static_roles) — concrete Stage-2 datapoint; a measurable re-framing of Finding 4's F1-axis loss.

## Top weaknesses (`top_weaknesses`) — P3 novelty-ordered

1. **[P3 highest-severity]** **Multi-Agent Debate (MAD) overlap UNADDRESSED empirically** — §2.2 prose-only discusses MAD in 2 sentences; **no main-table head-to-head**. Under adversarial reading, TCPB = MAD with {`aggregator_window = full_trajectory`, `aggregation_rule = terminal_F1_sign`} = parameter instantiation, not new mechanism. **D3 hard cap at 4 locked until benchmarked**.
2. **Framework-level novelty is framing-mostly** — "organizational emergence" is a rhetorical re-labeling of multi-agent routing; no new computational primitive proposed; Stage-2 mechanisms (R1/R2/R3) theoretical-only.
3. **Delivered Stage-1 ≈ MetaGPT-minus-orchestrator** — Prototype Scope Box (ii) self-admits "four role-prior nodes (decomposer, evidence_seeker, verifier, synthesizer)" = MetaGPT's fixed-role pipeline in reduced form; §3.1 "decentralized **within** fixed role-prior topology" concession further narrows the mechanistic delta.
4. **Zero external 2024-2025 SOTA in main tables** (S6 = 2.0) — compounds with D3 cap: novelty claims cannot be empirically distinguished from the very systems the paper is most similar to.
5. **No falsifiable claim prior work (AutoGen / ChatEval / MAD / MetaGPT / MA-RAG / ReAgent) cannot make** — §4.4 E1-E5 plan is reasonable but the experimental predictions (specialisation entropy, persona-divergence) are **symptoms of delegation, not mechanisms unique to EDO**. AutoGen could also produce these under appropriate configuration.
6. **Single benchmark + single seed + no paired CI** — cross-persona consensus across R-FULL-014/015/016/017/018/019.
7. **MA-RAG 2025 + ReAgent EMNLP 2025** missing from Related Work entirely — latest multi-hop QA SOTA for a 2026/2027 submission should be in §2 minimum + main-table head-to-head ideally.
8. **Figure 1 still placeholder** — Best-Paper dealbreaker.

## Core method problems (`core_method_problems`) — P3 adversarial

1. Novelty contribution ≈ rhetorical re-labeling of multi-agent orchestration; no new computational primitive.
2. Delivered Stage-1 TCPB is reduction of MAD (MAD with terminal-only aggregation = TCPB) by the paper's own equations.
3. Stage-2 R1/R2/R3 mechanisms are theoretical; unimplemented; §Limitations (1) concedes this.
4. "Near-homogeneous agents" claim in Abstract contradicts "4 role-prior nodes" in Prototype Scope Box (ii); paper honestly caveats this with "(in the full method)" but the caveat itself shows the framework-level novelty is promissory.

## Experimental design problems (`experimental_design_problems`)

1. Zero external baselines in main tables.
2. MAD not benchmarked despite §2.2 acknowledging overlap.
3. Single benchmark + single seed + no paired CI.
4. Table 2 ablations on non-canonical glm-4-flash with bit-identical null-effect rows.
5. No sensitivity sweep on safety-gate / force-forward / audit thresholds.
6. §4.5 single-seed fullval; paired CI deferred.

## Overclaims / risky framing (`overclaims_or_risky_claims`) — P3 SPECIALTY

1. **Abstract / §1 claim "organizational emergence"** — P3: this is a rhetorical frame, not a measured phenomenon; no metric specific to organisations-that-prior-systems-fail-on is proposed.
2. **§1 contribution #2 (recursive acceptance ladder)** — not in delivered prototype (Audit defaults to Accept); a future Stage-2 promise.
3. **§5 Conclusion "decentralized outcome-based calibration improves delegation safety (PAR=0)"** — Finding 3 attributes PAR=0 to safety gate, not TCPB; paper's own honest note but Conclusion still leans on the framing.
4. **§4.5 "reframes Finding 4 on cost-normalised axis +84% vs static_roles"** — P3: this is a denominator switch (dividing by tokens); on F1-axis the headline method still loses. **P3 reads: not a real reversal, a honest but marginal reframing**.
5. **Related Work §2 missing MA-RAG 2025 + ReAgent 2025** — for a 2026/2027 submission, omitting the 12-month SOTA is either unaware or selective.

## Ambiguous algorithm points — CLOSED (post-S-163/S-173)

All resolved.

## Missing definitions — CLOSED (post-S-163/S-173)

All resolved.

## Missing or weak experiments (`missing_or_weak_experiments`)

1. **[P3 highest priority]** No MAD head-to-head benchmark (D3 cap unlock requires this).
2. Zero external 2024-2025 SOTA in main tables (AutoGen / ChatEval / MA-RAG / ReAgent).
3. No MuSiQue / 2WikiMultiHop.
4. Only seed=42 fullval; seeds 43/44 pending.
5. No canonical-backbone ablation.
6. No case-study gallery.
7. No quantitative error taxonomy.

## Statistical significance concerns

1. Table 1 n=200 no paired bootstrap.
2. §4.5 single-seed fullval; paired CI deferred.

## Baseline completeness concerns — P3 specialty

1. **S6 = 2.0 "No external baselines at all"** — hard disqualifying.
2. **MAD specifically missing** — P3's #1 priority: without MAD head-to-head, D3 cap cannot lift above 4.
3. **MA-RAG 2025 + ReAgent EMNLP 2025 missing from Related Work** — 12-month SOTA absence is a presumption-of-unawareness signal for Best-Paper chairs.

## Limitations section assessment

| Field | Value |
|-------|--------|
| section_present | true |
| section_title_exact | true |
| contains_no_new_content | true |
| honesty_score_1_to_5 | 5 |
| specific_failure_modes_listed | true |
| issues | [] |

## Responsible NLP Checklist assessment

| Field | Value |
|-------|--------|
| appears_complete | true |
| issues | [] |

## What to fix for 8+ (target overall ≥ 8.0)

1. **[P3 priority #1]** **MAD head-to-head benchmark** on HotpotQA (and ideally MuSiQue) — closes D3 cap.
2. E-017 seed 43/44 + paired CI → D4 unlocks.
3. E-018 MA-RAG + ReAgent (+ AutoGen + ChatEval) external SOTA in main tables → S6 ≥ 5.
4. **Add MA-RAG 2025 + ReAgent EMNLP 2025 to §2 Related Work** with concrete mechanistic delta articulated.
5. MuSiQue second benchmark → EXP-1 close.
6. E-014 canonical ablation → S7 ≥ 5.
7. Replace Figure 1 placeholder.

## What to fix for Oral / Best-Paper (target overall ≥ 8.5)

1. All of 8+ **plus**:
2. **Implement ≥ 1 of R1/R2/R3 with measurable mechanistic-delta demonstration** (e.g. R2 audit: show EDO-with-audit beats MAD-with-same-aggregator on specific failure modes that MAD literature explicitly identifies).
3. **Formulate a falsifiable claim that AutoGen/ChatEval/MAD/MetaGPT/MA-RAG/ReAgent cannot match** — e.g. "specialisation entropy trajectory" or "persona-divergence convergence rate" with predictions that prior systems empirically fail.
4. **Reverse Finding 4 on F1-axis** (not just cost-normalised) on canonical backbone + 1 additional benchmark.
5. Case-study / application gallery with 6-10 visualisations.

## Recommended next actions

1. **[P3 highest priority non-quota-blocked]**: Rewrite §2.2 Multi-Agent Debate paragraph to ≥ 4-5 sentences: (i) state MAD mechanism concretely (per-hop critique + aggregator); (ii) state TCPB mechanism concretely (terminal-outcome + gradient-like peer-update); (iii) articulate **why TCPB is NOT a degenerate MAD**: e.g. "TCPB's competence-vector update is mechanistically different from MAD's aggregator because the signal is propagated through the delegation tree rather than the critique aggregator; MAD's aggregator operates on critiques, TCPB's update operates on accepted delivered value". This is a scientist writing task, NON-LLM, NOT blocked on quota; can be done in 30 min; closes the P3 overlap-risk-unaddressed flag even without MAD empirical benchmark.
2. **Add MA-RAG + ReAgent to §2 Related Work** — 1-2 sentences each, concrete mechanistic delta; non-LLM; 15 min.
3. Continue E-017 seed=43+44 (scheduler chained); E-014 canonical ablation; E-018 MA-RAG reproduce.
4. **MAD head-to-head (E-015/E-016)** — the single highest-leverage experiment for D3 cap unlock.
5. Figure 1 replacement.

## Rule source disagreements

None.

## Reference documents consulted

```
{
  "demand_md_loaded":           true,
  "edo_paper_pdf_loaded":       true (pdftotext -layout 103635 B / 923 lines / 15 pages),
  "fallback_source_used":       "pdftotext -layout",
  "layout_dependent_checks_blocked": ["DR-4 acl.sty modification audit"],
  "demand_section_11_applied":  true (7+3+2; oral_quality cap 3; P3 assigned 3.0),
  "persona_rotation":           "P3 Adversarial Novelty SAC; last used in R-FULL-013 on older PDF 87662BD6 (forced REJECT by DR-1 regression); first valid P3 verdict on post-S-173 clean PDF D6A67296",
  "5_persona_rotation_complete": "R-FULL-014 P5 / 015 P4 / 016 P1 / 017 P5 / 018 P2 / 019 P3 — all 5 personas now audited post-S-173 PDF D6A67296; full consensus overall=4.5 weak_reject across 5 personas over 6 consecutive batches",
  "weighted_pre_cap_19_round_trajectory": "5.925→5.925→5.905→4.985→4.910→4.560→4.725→5.105→4.940→4.765→4.975→4.410→5.275→5.100→5.495→5.580→5.490→5.350→5.315→**5.260 (R-FULL-019 P3)**. P3 systematic stricter by -0.055 vs R-FULL-018 P2 / -0.090 vs R-FULL-017 P5 / -0.230 vs R-FULL-015 P4 on novelty + significance bars.",
  "p3_verdict_rationale":       "P3 novelty-adversarial audit finds: (1) MAD overlap risk true + unaddressed empirically → D3 hard cap at 4; (2) Framework-level novelty is framing-mostly; delivered Stage-1 ≈ MetaGPT-minus-orchestrator; Stage-2 R1/R2/R3 theoretical-only; (3) No falsifiable claim prior work cannot make; §4.4 E1-E5 predictions are delegation-symptom proxies, not EDO-mechanism-unique; (4) MA-RAG 2025 + ReAgent EMNLP 2025 missing from Related Work = presumption-of-unawareness signal for Best-Paper chairs. overall=4.5 cap-bound at D3<5 + D4<5 tied caps; weighted_pre_cap=5.260 confirms D1/D5/D7 hygiene saturated, novelty + experiments are the binding constraints."
}
```

---

## `_parse_mode`

`full`

*End of review. **R-FULL-019 completes 5-persona rotation (P1/P2/P3/P4/P5) on post-S-173 PDF `D6A67296`. 6 consecutive batches at overall=4.5 weak_reject across all 5 personas = robust sprint consensus: D1/D5/D7 hygiene is saturated; D3 (novelty via MAD overlap) + D4 (experiments_solidity) are the two sole binding caps; sprint critical path (E-017 seed=43/44 + paired CI + E-014/E-015/E-016/E-018 external SOTA including MAD head-to-head + MuSiQue) is the path to overall ≥ 5.0 weak_accept.** P3's unique actionable recommendation: **rewrite §2.2 MAD paragraph with concrete mechanistic delta (non-LLM, 30 min)** — this closes the overlap-risk-unaddressed flag even before MAD empirical benchmark, potentially lifting D3 from 4 to 5 → overall 4.5 → 5.0.*
